Richter P, Lotze W
Zentralbl Gynakol. 1987;109(4):228-34.
In cases of progressive, primary palliatively operated ovarian carcinoma or of such with unresectable tumors (stage III and IV) antineoplastic chemotherapy is preferred. Second-look laparotomy with the aim of radical operation is indicated in cases of established tumor remission. In our clinic 37 second-look operations were carried out in the period between 1975 and 1982, in 30 cases (81%) a secondary radical operation was possible. 56.8% of the patients were relaparotomised 2 to 5 months after the first operation, 13.5% after 6 to 9 months and 29.7% not before more than 10 months after the first operation. The average age was 51.4 years. Clinically established tumor remission (CR = 14, PR = 17) was proven intraoperatively in 31 women (83.8%). In 6 cases of them (16.2%) there existed no more tumor from a histological viewpoint, and in three cases (8.1%) tumor structures could be proven only by means of a microscope. Prior to this all patients had undergone a combined chemotherapy by CPM, MTX, 5-FU and VBL, 8 women (21.6%) underwent an additional loco-regional chemotherapy by 5-FU and MTX. The 5-years survival rate amounts to 50.2%. After remission the average survival amounts to 39.8 months, otherwise it is only 14 months. This is significantly prolonged in cases of secondary operations after more than 10 months.
对于进展期、初次接受姑息性手术的卵巢癌或肿瘤无法切除(Ⅲ期和Ⅳ期)的患者,首选抗肿瘤化疗。对于已确定肿瘤缓解的患者,建议进行旨在根治性手术的二次探查剖腹术。在我们诊所,1975年至1982年间进行了37例二次探查手术,其中30例(81%)可行二次根治性手术。56.8%的患者在首次手术后2至5个月进行了再次剖腹术,13.5%在6至9个月后进行,29.7%在首次手术后超过10个月才进行。平均年龄为51.4岁。31名女性(83.8%)术中证实临床确定的肿瘤缓解(完全缓解=14例,部分缓解=17例)。其中6例(16.2%)从组织学角度看已无肿瘤,3例(8.1%)仅通过显微镜才能证实肿瘤结构。在此之前,所有患者均接受了环磷酰胺、甲氨蝶呤、5-氟尿嘧啶和长春碱的联合化疗,8名女性(21.6%)额外接受了5-氟尿嘧啶和甲氨蝶呤的局部区域化疗。5年生存率为50.2%。缓解后的平均生存期为39.8个月,否则仅为14个月。首次手术后超过10个月进行二次手术的患者生存期明显延长。